Fertility Preservation Iatrogenic denied as non-formulary by Aetna?

Aetna's specific coverage criteria for FERTILITY PRESERVATION IATROGENIC are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Issues a Non-Formulary Denial for Iatrogenic Fertility Preservation — and How to Appeal

Iatrogenic fertility preservation involves a combination of services — consultation, monitoring, medications (stimulation agents), and the retrieval or banking procedure itself. Aetna may issue a non-formulary denial when one or more of the medications used in an ovarian stimulation or other preservation protocol are not on Aetna's preferred drug list, or when a specific compounded preparation is used. The non-formulary denial may arrive separately from (or in addition to) any procedural claim denial, and patients sometimes receive it without realizing a formulary alternative was available or that an exception process exists.

## Why This Denial Is Appealable

Non-formulary medication denials in this context are appealed on one of two grounds: (1) medical necessity for the specific agent — the treating physician required this particular drug because a formulary alternative was clinically inappropriate or contraindicated for this patient; or (2) absence of a true therapeutic alternative on the formulary. Either ground can support a non-formulary exception, and many plans grant exceptions routinely when properly documented clinical justification is provided.

## Your Federal Appeal Rights

• Internal appeal: Under ERISA §503 (employer plans) or applicable state law, you are entitled to a full-and-fair internal review. File within the deadline on your EOB — typically 180 days.
• Formulary exception request: File this through Aetna's formulary exception process simultaneously with the formal appeal — the two processes are separate but can run in parallel, and a granted exception resolves the denial faster.
• External review: Under ACA §2719, binding independent external review is available once internal remedies are exhausted. Total window approximately four months. Expedited review (72 hours) is available when the underlying treatment timeline is urgent.

## Concrete Appeal Steps and Timeline

1. Identify the specific denied medication(s) — confirm the drug name and the formulary tier status from Aetna's published formulary. 2. Identify any formulary alternatives Aetna would have covered — your prescribing physician needs to address each one specifically. 3. File the formulary exception request through Aetna's standard process, concurrent with the formal internal appeal. 4. Escalate to external review if both the exception and appeal are denied.

## Documentation to Gather

• Prescribing physician letter: Explains why the specific agent was chosen, why each listed formulary alternative is clinically inappropriate or insufficient for this patient's specific protocol, and why the selected drug is medically necessary for this clinical situation.
• Adverse reaction or intolerance records: If prior exposure to a formulary alternative caused problems, include chart documentation of that history.
• Reproductive endocrinologist protocol notes: The specific stimulation or preservation protocol chosen and the clinical rationale for each medication component.
• Urgency documentation: If the underlying oncologic treatment timeline makes substituting to a formulary alternative clinically impractical, document that urgency explicitly.
• Aetna formulary and exception criteria: Print the formulary tier for the denied drug and the published formulary exception criteria — address each criterion directly in the appeal letter.

## Criteria-Mapping Structure

In your appeal letter, reproduce Aetna's formulary exception criteria. For each criterion, provide the specific chart-based answer: why the formulary alternative is inadequate (by name, for each alternative), why the chosen drug is appropriate for this patient's clinical situation, and the physician's direct attestation. A criterion-by-criterion response, rather than a general narrative, is the most reliable path to reversal on a non-formulary denial.